196 related articles for article (PubMed ID: 18957895)
1. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
Okura Y; Kohyama K; Park IK; Matsumoto Y
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
[TBL] [Abstract][Full Text] [Related]
2. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
3. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
Okura Y; Miyakoshi A; Kohyama K; Park IK; Staufenbiel M; Matsumoto Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9619-24. PubMed ID: 16769900
[TBL] [Abstract][Full Text] [Related]
4. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
[TBL] [Abstract][Full Text] [Related]
6. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.
Takata K; Kitamura Y; Yanagisawa D; Morikawa S; Morita M; Inubushi T; Tsuchiya D; Chishiro S; Saeki M; Taniguchi T; Shimohama S; Tooyama I
FEBS Lett; 2007 Feb; 581(3):475-8. PubMed ID: 17240371
[TBL] [Abstract][Full Text] [Related]
7. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
9. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
10. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
Seabrook TJ; Jiang L; Maier M; Lemere CA
Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
13. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
Okura Y; Matsumoto Y
Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
15. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
[TBL] [Abstract][Full Text] [Related]
17. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L
Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064
[TBL] [Abstract][Full Text] [Related]
19. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
Bard F; Cannon C; Barbour R; Burke RL; Games D; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Lieberburg I; Motter R; Nguyen M; Soriano F; Vasquez N; Weiss K; Welch B; Seubert P; Schenk D; Yednock T
Nat Med; 2000 Aug; 6(8):916-9. PubMed ID: 10932230
[TBL] [Abstract][Full Text] [Related]
20. Complement component C1q modulates the phagocytosis of Abeta by microglia.
Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]